Autopsy report · NCT03288818

Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides

“Funding discontinued”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Sponsor type

University, hospital or other

Conditions

Mycosis Fungoides

Interventions

Mechlorethamine Hydrochloride Gel; Total Skin Electron Beam Radiation Therapy

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Safety Study of Nebivolol for COPD Patients
  “Funding was discontinued.” (95% match in meaning)
• A Study of APR-246 in Oesophageal Cancer
  “Funding ceased” (89% match in meaning)
• Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
  “Funding Stopped” (87% match in meaning)
• Evaluation and Adverse Event Surveillance for Initial Implementation of ShangRing Circumcision in Mozambique
  “Funding no longer available” (87% match in meaning)
• Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy
  “no longer had funding to continue” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.